Congratulations to @MerrynVoysey on your public disclosure, “Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate vaccines: a systematic review and network meta-analysis of individual participant data” @UniofOxford https://t.co
Immunogenicity and seroefficacy of 10-valent and 13-valent pneumococcal conjugate #vaccines Higher antibody response after vaccination was associated with a lower risk of subsequent infection. @MerrynVoysey https://t.co/bZcgBJdNXU https://t.co/WOnAwzrP
10- and 13-valent pneumococcal conjugate vaccine (#PCV), both recommended by the #WHO, which one elicits better immune response and provides better protection? Our recent study in @eClinicalMedicine shows serotype-specific differences between two vaccines: